66th ASH Annual Meeting: ASH-FDA Joint Symposium II

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member

denotes an abstract that is clinically relevant.

denotes that this is a recommended PHD Trainee Session.

denotes that this is a ticketed session.

ASH-FDA Joint Symposium II

Special-Interest Sessions

Treatment Considerations

Room 7 (San Diego Convention Center)